Will the 2026 Nobel Prize in Physiology or Medicine focus on immunotherapy by October 5?

⚡ Immunotherapy has won twice since 2018; strong contender0 votes

Yes

—

Cast your vote

Yes—

No—

Votes only — no stakes, just conviction.

✨ AI says 48% Yes

Immunotherapy is a perennial favorite with three Nobel wins since 2015, but the Nobel Committee often recognizes diverse fields; competition from aging/longevity, CRISPR variants, and other breakthroughs is intense.

Rules

Resolves YES if the Nobel Assembly's official announcement at nobelprize.org cites immunotherapy (CAR-T, checkpoint inhibitors, or related cancer/disease immunology advances) as the primary rationale for the 2026 prize.

Share this with an ambitious friend